192 related articles for article (PubMed ID: 33938917)
1. Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial.
White HD; O'Brien SM; Alexander KP; Boden WE; Bangalore S; Li J; Manjunath CN; Lopez-Sendon JL; Peteiro J; Gosselin G; Berger JS; Maggioni AP; Reynolds HR; Hochman JS; Maron DJ
JAMA Cardiol; 2021 Sep; 6(9):1023-1031. PubMed ID: 33938917
[TBL] [Abstract][Full Text] [Related]
2. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial.
Sanchis J; Bueno H; Miñana G; Guerrero C; Martí D; Martínez-Sellés M; Domínguez-Pérez L; Díez-Villanueva P; Barrabés JA; Marín F; Villa A; Sanmartín M; Llibre C; Sionís A; Carol A; García-Blas S; Calvo E; Morales Gallardo MJ; Elízaga J; Gómez-Blázquez I; Alfonso F; García Del Blanco B; Núñez J; Formiga F; Ariza-Solé A
JAMA Intern Med; 2023 May; 183(5):407-415. PubMed ID: 36877502
[TBL] [Abstract][Full Text] [Related]
3. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
[TBL] [Abstract][Full Text] [Related]
4. Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
Lopez-Sendon JL; Cyr DD; Mark DB; Bangalore S; Huang Z; White HD; Alexander KP; Li J; Nair RG; Demkow M; Peteiro J; Wander GS; Demchenko EA; Gamma R; Gadkari M; Poh KK; Nageh T; Stone PH; Keltai M; Sidhu M; Newman JD; Boden WE; Reynolds HR; Chaitman BR; Hochman JS; Maron DJ; O'Brien SM
Eur Heart J; 2022 Jan; 43(2):148-149. PubMed ID: 34514494
[TBL] [Abstract][Full Text] [Related]
5. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
[TBL] [Abstract][Full Text] [Related]
6. Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.
Reynolds HR; Shaw LJ; Min JK; Spertus JA; Chaitman BR; Berman DS; Picard MH; Kwong RY; Bairey-Merz CN; Cyr DD; Lopes RD; Lopez-Sendon JL; Held C; Szwed H; Senior R; Gosselin G; Nair RG; Elghamaz A; Bockeria O; Chen J; Chernyavskiy AM; Bhargava B; Newman JD; Hinic SB; Jaroch J; Hoye A; Berger J; Boden WE; O'Brien SM; Maron DJ; Hochman JS;
JAMA Cardiol; 2020 Jul; 5(7):773-786. PubMed ID: 32227128
[TBL] [Abstract][Full Text] [Related]
7. Survival After Invasive or Conservative Management of Stable Coronary Disease.
Hochman JS; Anthopolos R; Reynolds HR; Bangalore S; Xu Y; O'Brien SM; Mavromichalis S; Chang M; Contreras A; Rosenberg Y; Kirby R; Bhargava B; Senior R; Banfield A; Goodman SG; Lopes RD; Pracoń R; López-Sendón J; Maggioni AP; Newman JD; Berger JS; Sidhu MS; White HD; Troxel AB; Harrington RA; Boden WE; Stone GW; Mark DB; Spertus JA; Maron DJ;
Circulation; 2023 Jan; 147(1):8-19. PubMed ID: 36335918
[TBL] [Abstract][Full Text] [Related]
8. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
[TBL] [Abstract][Full Text] [Related]
9. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
[TBL] [Abstract][Full Text] [Related]
10. Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.
Herzog CA; Simegn MA; Xu Y; Costa SP; Mathew RO; El-Hajjar MC; Gulati S; Maldonado RA; Daugas E; Madero M; Fleg JL; Anthopolos R; Stone GW; Sidhu MS; Maron DJ; Hochman JS; Bangalore S
J Am Coll Cardiol; 2021 Jul; 78(4):348-361. PubMed ID: 33989711
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Reynolds HR; Cyr DD; Merz CNB; Shaw LJ; Chaitman BR; Boden WE; Alexander KP; Rosenberg YD; Bangalore S; Stone GW; Held C; Spertus J; Goetschalckx K; Bockeria O; Newman JD; Berger JS; Elghamaz A; Lopes RD; Min JK; Berman DS; Picard MH; Kwong RY; Harrington RA; Thomas B; O'Brien SM; Maron DJ; Hochman JS;
J Am Heart Assoc; 2024 Mar; 13(5):e029850. PubMed ID: 38410945
[TBL] [Abstract][Full Text] [Related]
12. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Spertus JA; Jones PG; Maron DJ; O'Brien SM; Reynolds HR; Rosenberg Y; Stone GW; Harrell FE; Boden WE; Weintraub WS; Baloch K; Mavromatis K; Diaz A; Gosselin G; Newman JD; Mavromichalis S; Alexander KP; Cohen DJ; Bangalore S; Hochman JS; Mark DB;
N Engl J Med; 2020 Apr; 382(15):1408-1419. PubMed ID: 32227753
[TBL] [Abstract][Full Text] [Related]
13. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracoń R; Spertus JA; Broderick S; Bangalore S; Rockhold FW; Ruzyllo W; Demchenko E; Nageh T; Grossman GB; Mavromatis K; Manjunath CN; Smanio PEP; Stone GW; Mancini GBJ; Boden WE; Newman JD; Reynolds HR; Hochman JS; Maron DJ;
Circ Cardiovasc Interv; 2024 Jun; 17(6):e013435. PubMed ID: 38629312
[TBL] [Abstract][Full Text] [Related]
15. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial.
Sanchis J; Bueno H; García-Blas S; Alegre O; Martí D; Martínez-Sellés M; Domínguez-Pérez L; Díez-Villanueva P; Barrabés JA; Marín F; Villa A; Sanmartín M; Llibre C; Sionís A; Carol A; Fernández-Cisnal A; Calvo E; Morales MJ; Elízaga J; Gómez I; Alfonso F; García Del Blanco B; Formiga F; Núñez E; Núñez J; Ariza-Solé A
JAMA Netw Open; 2024 Mar; 7(3):e240809. PubMed ID: 38446482
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
[TBL] [Abstract][Full Text] [Related]
17. [Comparative efficacy of conservative and invasive treatment of patients with stable form of ischemic heart disease (according to results of five year prospective study)].
Komarov AL; Iliushenko TA; Shakhmatova OO; Deev AD; Samko AN; Panchenko EP
Kardiologiia; 2012; 52(8):4-14. PubMed ID: 23098392
[TBL] [Abstract][Full Text] [Related]
18. Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.
Fanaroff AC; Cyr D; Neely ML; Bakal J; White HD; Fox KAA; Armstrong PW; Lopes RD; Ohman EM; Roe MT
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004755. PubMed ID: 30562068
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.
Boden WE; O'Rourke RA; Crawford MH; Blaustein AS; Deedwania PC; Zoble RG; Wexler LF; Kleiger RE; Pepine CJ; Ferry DR; Chow BK; Lavori PW
N Engl J Med; 1998 Jun; 338(25):1785-92. PubMed ID: 9632444
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial.
Barnett PG; Chen S; Boden WE; Chow B; Every NR; Lavori PW; Hlatky MA
Circulation; 2002 Feb; 105(6):680-4. PubMed ID: 11839621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
